Abstract-The pharmacological profile of a new alpha-1 adrenoceptor antagonist, a -ethyl 3,4,5 trimethoxy a (3 ((2 (2 methoxyphenoxy)ethyl) amino) propyl) benzene acetonitrile fumarate (HV-723), was studied in vitro. In dog mesenteric arteries, HV-723, prazosin and yohimbine competitively inhibited noradrenaline induced contraction: the pA2 value of HV-723 (9.37) was apparently larger than that of prazosin (8.22) and yohimbine (7.18).
Abstract-The pharmacological profile of a new alpha-1 adrenoceptor antagonist, a -ethyl 3,4,5 trimethoxy a (3 ((2 (2 methoxyphenoxy)ethyl) amino) propyl) benzene acetonitrile fumarate (HV-723), was studied in vitro. In dog mesenteric arteries, HV-723, prazosin and yohimbine competitively inhibited noradrenaline induced contraction: the pA2 value of HV-723 (9.37) was apparently larger than that of prazosin (8.22) and yohimbine (7.18).
However, HV-723 showed no or only a slight inhibition on the contractile responses to 5-HT, KCI and prostaglandin Fla. HV-723 also showed potent alpha-1 adrenoceptor antagonist activity in the dog mesenteric and saphenous veins.
However, HV-723 showed little antagonist activity on the pre and postsynaptic alpha-2 adrenoceptors, beta-1 and beta-2 adrenoceptors and muscarinic receptors. HV-723 also inhibited the sympathetic contraction induced by electrical transmural stimulation in the dog mesenteric arteries, and the inhibition of HV-723 was about 10 times more potent than that of prazosin.
However, 3H-noradrenaline release evoked by electrical stimulation was not influenced by HV-723.
These results clearly show that HV-723 is a potent and selective alpha-1 adrenoceptor antagonist.
Alpha -adrenoceptors
have been phar macologically classified into alpha-1 and alpha-2 subtypes based on the development of selective agonists and antagonists (1) (2) (3) . In general, alpha-1 adrenoceptors are most selectively activated by phenylephrine and antagonized by prazosin. In contrast, alpha-2 adrenoceptors are preferentially activated by clonidine, BHT-933 and UK-14304 and an tagonized by yohimbine and rouwolsine.
Alpha-1 adrenoceptors in blood vessels are postsynaptic receptors mediating vaso constriction, and the therapy with selective alpha-1 adrenoceptor antagonists is now established in the treatment of hypertension and cardiac failure (4) .
We tried to develop a more selective alpha-1 adrenoceptor antagonist and found that a new compound, a-ethyl -3,4,5-trime thoxy-a-(3-((2-(2-methoxyphenoxy)ethyl) amino) propyl)benzeneacetonitrile fumarate (HV-723) (Fig. 1 ) , has a higher affinity to alpha-1 adrenoceptors than prazosin. In this paper, we report the selectivity of HV-723 for alpha-1 adrenoceptors, as compared to prazosin and yohimbine. 
Materials and Methods Experiments
with dog vascular vessels: Dogs of either sex, weighing 8-12 kg, were anesthetized with thiopental sodium (20 mg/ kg, i.v.) and exsanguinated from the common carotid arteries. Mesenteric artery and mesen teric and saphenous veins were isolated.
For the measurement of mechanical re sponse, the blood vessels were helically cut approximately 2 mm in width and 15 mm in length, under a dissecting microscope. The strips were mounted vertically in an organ bath containing 10 ml of Krebs-Henseleit solution of following composition:
118 mM NaCl, 4.7 mM KCI, 2.6 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 25 mM NaHCO3 and 11.1 mM glucose.
The bath medium was maintained at 37'C, pH 7.4, and was equilibrated with a gas mixture consisting Of 95% 02 and 5% C02, during both preincubation and experimental periods. A resting tension of 1.5 g and 0.5 g was applied to the artery and veins, respec tively, and the responses were recorded iso metrically. All preparations were equilibrated for 90 min before starting the experiments. Cumulative concentration-response curves of agonists such as noradrenaline were deter mined by step-wise increase in the concen tration of an agonist as soon as a steady response to the previous administration had been achieved. Antagonists to be tested were applied at least 30 min before recording the concentration-response curve. To block the beta adrenoceptors, 10-6 M propranolol was added to the bath solution throughout the experiments. When the response to clonidine in the dog saphenous vein was recorded, the preparations were treated with phenoxy benzamine (10-7 M) and indomethacin (3X10-6 M).
Electrical transmural stimulation was ap plied through a pair of platinum-wire elec trodes. In this case, the preparation was placed in parallel between the electrodes. The distance between the electrodes was ap proximately 2 mm, this being sufficiently narrow to assure that the tension change would not be disturbed. Stimulus parameters were 0.3 msec in duration and supramaximal voltage for 10 sec and 10 Hz. Drugs were applied at least 15 min before stimulation.
The release of 3H-noradrenaline was de termined according to the method reported by Muramatsu et al. (5). The strips were preincubated with 3H-noradrenaline (2X10-7 M) in Krebs-Henseleit solution containing 5.7X10-4 M ascorbic acid for 90 min at 37'C. These strips were suspended between a pair of parallel platinum-wire electrodes under 1.0 g of tension. The Krebs-Henseleit solution containing 5.7 X 10-4 M ascorbic acid, 10-6 M cocaine and 10-5 M cortico sterone was bubbled with 95% 02 and 5% CO2 at 37°C and was superfused using a peristaltic pump at the flow rate of 1 ml/min. Before starting the experiments, each arterial strip was equilibrated for 90 min, after which electrical transmural stimulation was applied through a pair of electrodes. Stimulus para meters were a frequency of 3 Hz, duration of 0.1 msec and supramaximal voltage for 10 sec. Superfusate solution was collected every 1 min, and the radioactivity was deter mined by counting in Aloka LSC 653 liquid scintillation spectrometer.
The spontaneous 3H-efflux decreased exponentially to reach a plateau during the equilibration period for 60-90 min. Thus, the increase in 3H-efflux induced by electrical transmural stimulation was calculated to be the net 3H-efflux by stimulation.
The drugs to be tested were superfused 20 min before initiation of elec trical transmural stimulation.
Experiments with rat vas deferens: The prostatic portion of vasa was vertically sus pended in the organ bath containing Krebs Henseleit solution at 37'C under 1.0 g resting tension. Alpha-2 adrenoceptor an tagonist activity was assessed by the deter mination of the pA2 value against the in hibitory effect of clonidine on the contractile response to the electrical transmural stimula tion (0.3 msec, suparmaximal voltage, 0.1 Hz). Propranolol at 10-6 M was added to the bath medium.
Drugs: HV-723 (a-ethyl -3,4,5-trimethoxy a-(3-((2 (2 methoxyphenoxy)ethyl) amino) propyl)benzeneacetonitrile fumarate, Fig. 1 
Results
Effects on the responses to noradrenaline and other drugs in the dog mesenteric arteries: HV-723 at concentrations ranging from 10-10 M to 10-7 M had no significant effect on the resting tension of the dog mesenteric artery. However, the compound inhibited the contractile response to nor adrenaline. Figure 2 shows the concentration response curves before and after treatment with various concentrations of HV-723, together with the cases of two control drugs (prazosin and yohimbine).
HV-723 and the control drugs competitively inhibited the responses to noradrenaline, as the slope factors were nearly equal to unity ( Table 1) . The pA2 value of HV-723 was apparently higher than that of prazosin and yohimbine (Table 1) .
On the other hand, HV-723 showed no or only a slight inhibition on the contractile responses to 5-HT, KCI and prostaglandin F2a. Figure 3 shows the concentration response curves of three agonists before and after treatment with 10-7 M HV-723. HV 723 slightly shifted the concentration response curve of 5-HT to the right and attenuated the maximum contraction induced by KCI. Effects on alpha-1, alpha-2 and beta adrenoceptors and muscarinic receptors: Selectivity of HV-723 for alpha-1 and alpha-2 adrenoceptors was examined in several tissues and was compared with that of prazosin and yohimbine. Alpha-1 adre noceptor-mediated responses were recorded in the dog mesenteric artery and vein (against noradrenaline-response) and in the dog saphenous vein (against phenylephrine response).
Postsynaptic and presynaptic alpha-2 adrenoceptor mediated responses were recorded in the dog saphenous vein (against clonidine-response in the presence of phenoxybenzamine) and in the rat vas deferens (against clonidine-response), re spectively. HV-723, prazosin and yohimbine at 10-7 M shifted the concentration-response curves to the right without attenuating the maximum responses. Table 2 shows the EC50 values of each agonist in the absence and presence of 10-7 M or 10-6 M antagonist and their ratios. HV-723 and prazosin selectively inhibited the alpha-1 adrenoceptor-mediated responses either with a slight or no effect on the alpha-2 adrenoceptor-mediated re sponses. Comparison of the ratios indicated that the antagonist activity of HV-723 for alpha-1 adrenoceptors was approximately 10 times more potent than that of prazosin. Yohimbine was more selective for alpha-2 rather than alpha-1 adrenoceptors.
HV-723 (10-7 and 10-6 M) had no effect on positive inotropic and chronotropic re sponses to isoproterenol in the guinea-pig atria, on the relaxing response to isopro terenol in the guinea-pig trachea and on the contractile response to acetylcholine in the guinea-pig ileum (data not shown). •, before; A, after treatment with 10-7 M HV-723. Each value is the mean±S.E. of 5-6 experiments. Effects on the responses to electrical transmural stimulation in the dog mesenteric artery: Electrical transmural stimulation at 10 Hz produced a transient contraction in the dog mesenteric artery. This contraction was completely inhibited by 3x`10-7 M tetrodo toxin or 3X10-6 M guanethidine (data not shown). HV-723 and prazosin inhibited but did not abolish this contraction (Fig. 4) . The inhibition was concentration-dependent: the 
Effects
on the 3H-efflux induced by electrical transmural stimulation in the dog mesenteric artery: In order to examine the presynaptic effect of HV-723, 3H-efflux was measured in the dog mesenteric artery which had been preincubated with 3H-noradre naline. Electrical transmural stimulation at 3 Hz resulted in an increase in the 3H-efflux. This evoked efflux was abolished by 3x10-7 M tetrodotoxin or 3X10-6 M guanethidine (data not shown).
HV-723 and prazosin (10-8-10-7 M for each drug) had no sig nificant effect on the basal and evoked 3H efflux, but at 10-6 M, both the drugs slightly increased the efflux (Fig. 5) . Yohimbine (10-8-10-6 M) increased the evoked 3H efflux twice.
Discussion
Postsynaptic alpha adrenoceptors of the dog mesenteric artery have been charac terized as the alpha-1 subtype (7, 8). In the present study also, prazosin and yohimbine competitively inhibited the concentration response curve of noradrenaline, and the pA2 value of prazosin was much higher than that of yohimbine (Table 1 ) . Under the same conditions, HV-723, a new compound, shifted the concentration-response curve of noradrenaline to the right, and the slope factor of the Schild plot was nearly equal to unity. Furthermore, the estimated pA2 value of HV-723 was significantly larger than that of prazosin. These results suggest that HV 723 shows a potent and competitive alpha-1 adrenoceptor antagonist activity in the dog mesenteric artery.
Such alpha-1 antagonist action was also observed in the dog mesenteric and saphe nous veins, and the potency was higher than that of prazosin. However, HV-723 had little or no antagonist action against pre and postsynaptic alpha-2 adrenoceptors, beta adrenoceptors and muscarinic receptors. Fur thermore, the contractile responses to 5-HT, KCI and PGF2a in the dog mesenteric artery were little affected by HV-723 at concen trations which caused a large reduction in the noradrenaline-response.
These results sug gest that the antagonist action of HV-723 is selective for alpha-1 adrenoceptors.
Since it has been recently demonstrated that sympathetic contraction of the dog mesenteric artery and other blood vessels consists of not only adrenergic but also purinergic components (9-12), we decided to examine the effects of HV-723 on the sympathetic response of the dog mesenteric artery. The results shown in Fig. 4 indicate that the sympathetic contraction was par tially inhibited by HV-723 or prazosin and that the combined treatment with both drugs failed to produce further reduction of the sympathetic response. These results suggest that the drugs selectively attenuate the adren ergic component of sympathetic contraction. The results in Fig. 4 also show that the inhibitory action of HV-723 was produced at lower concentrations than that of prazosin. Since no presynaptic action of HV-723 and prazosin was observed, it is likely that the difference of the potencies reflects the difference in the affinities of both the drugs on the postsynaptic alpha-1 adrenoceptors. In conclusion, the present in vitro study clearly shows that the newly synthesized compound HV-723 is a more potent and selective alpha-1 adrenoceptor antagonist as compared with prazosin, and suggests that it may be applicable for the treatment of diseases associated with alpha-1 adreno ceptors.
